[1] PEGORARO V,URBINATI D,VISSER G H A,et al.Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility:a preventable disease that still produces significant morbidity and mortality in children[J].PLoS One,2020,15(7):e0235807.
[2] 凤婧,袁佳,王海娟,等.高抗-D效价孕产妇产前管理及新生儿救治[J].中国输血杂志,2019,32(2):171-174.
[3] 李翠莹,李小薇.胎儿新生儿溶血病实验室检测专家共识[J].临床输血与检验,2021,23(1):20-23.
[4] OEPKES D,SEAWARD P G,VANDENBUSSCHE F P H A,et al.Doppler ultrasonography versus amniocentesis to predict fetal anemia[J].N Engl J Med,2006,355(2):156-164.
[5] PRETLOVE S,FOX C,KHAN K,et al.Noninvasive methods of detecting fetal anaemia:a systematic review and meta‐analysis[J].BJOG, 2009, 116(12):1558-1567.
[6] MARI G,DETER R L,CARPENTER R L,et al.Noninvasiv e diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization.Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses[J].N Engl J Med,2000,342(1):9-14.
[7] FUNG,M.K, EDER, A.F, SPITALNIK,S.L, et al.Technica
l Manual[M].19th edn.American Association of Blood Banks (AABB), Bethesda.2020.
[8] KLEIN, H.G, ANSTEE, D.J.Mollison's Blood Transfusion in Clinical Medicine[M].11th edn.Blackwell Publishing, Oxford, UK, Chapter 8, 322.
[9] EVANS M L,HOLMES B,DOWLING K,et al.Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti-D in pregnancy[J].Transfus Med Oxf Engl,2021,31(1):36-42.
[10] BRUCE D G,TINEGATE H N,WILLIAMS M,et al.Antenatal monitoring of anti-D and anti-c:could titre scores determined by column agglutination technology replace continuous flow analyser quantification?[J].Transfus Med,2013,23(1):36-41.
[11] WIKMAN A,JALKESTEN E,AJNE G,et al.Anti-D quantification in relation to anti-D titre,middle cerebral artery Doppler measurement and clinical outcome in RhD-immunized pregnancies[J].Vox Sang,2018,113(8):779-786.
[12] GWEN C.Intrauterine Transfusion:an international review of practice and policy[J].ISBT Sci Ser,2020,15(3):342-346.
[13] SOCIETY for Maternal-Fetal Medicine (SMFM) Electronic address:pubs@smfm org,MARI G,NORTON M E,et al.Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8:the fetus at risk for anemia—diagnosis and management[J].Am J Obstet Gynecol,2015,212(6):697-710.
[14] NICOLAIDES K H,CLEWELL W H,MIBASHAN R S,et al.Fetal haemoglobin measurement in the assessment of red cell isoimmunisation[J].Lancet,1988,331(8594):1073-1075.
[15] AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS' COMMITTEE ON OBSTETRIC PRACTICE S F M F M.Medically indicated late-preterm and early-term deliveries:ACOG committee opinion,number 831[J].Obstet Gynecol,2021,138(1):e35-e39.
[16] DETTI L,OZ U,GUNEY I,et al.Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization[J].Am J Obstet Gynecol,2001,185(5):1048-1051.
[17] SCHEIER M,HERNANDEZ-ANDRADE E,FONSECA E B,et al.Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions[J].Am J Obstet Gynecol,2006,195(6):1550-1556. |
